Mark Yanta, MD
Otolaryngology · Alpharetta, GANPI 1245239094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 50.8% of the total. 2025 is the largest year on record at $1,595, 2.3 times the $681 reported in 2019. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $40.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$772
- Optinose US, Inc.$669
- Sanofi$450
- Stryker$192
- Aerin Medical Inc.$171
- plus $631 from 12 others
What the payments were for
- Food & beverage$5,75298%
- Education$1142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 45 | $2,981 |
| Regeneron Healthcare Solutions, Inc. | 20 | $772 |
| Optinose US, Inc. | 42 | $669 |
| Sanofi | 11 | $450 |
| Stryker | 5 | $192 |
| Aerin Medical Inc. | 2 | $171 |
| Medtronic | 2 | $127 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| GSK | 5 | $113 |
| Medical Device Business Services, Inc. | 3 | $89 |
| Spirair, Inc. | 1 | $46 |
| Acclarent, Inc | 2 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $29 |
| Merck | 1 | $22 |
| Intersect ENT, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Kaleo, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$1,188
- Inspire$536
- DUPIXENT$215
- VIVAER STYLUS$146
- RHINAER STYLUS$146
- SUNOSI$122
- STEALTHSTATION S8 PLATFORM$105
- Xhance$102
How this compares
$5,865 in reported general payments places this provider in the 90th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $49,836 |
| XhanceFluticasone Propionate | 14 | $10,454 |
| Azelastine Hcl | 323 | $8,444 |
| Ipratropium Bromide | 143 | $3,857 |
| Fluticasone Propionate | 164 | $1,716 |
| CefuroximeCefuroxime Axetil | 16 | $222 |
| Doxycycline Hyclate | 25 | $157 |
| Mupirocin | 24 | $117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $76 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $45 |
| Montelukast Sodium | 14 | $31 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $669 | $10,45414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 308 otolaryngology providers in Georgia.
Other otolaryngology in Alpharetta
- Dozier HoodFayetteville$347K
- Christopher MelroySavannah$298K
- Karen HoffmannAtlanta$223K
- Jose StolovitzkyAtlanta$81K
- Jonathan LindmanEvans$55K
- Gregory PostmaAugusta$37K
- Oswaldo HenriquezSmyrna$15K
- Donald BrowningLawrenceville$14K
- Robert GadlageDuluth$14K
- Lawrence WeissMarietta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.